JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) - Total Assets

Latest as of June 2026: $55.84 Million USD

Based on the latest financial reports, JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) holds total assets worth $55.84 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares - Total Assets Trend (2018–2025)

This chart illustrates how JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's total assets have evolved over time, based on quarterly financial data. Also see ZJYL stock market capitalisation for the company's overall valuation and market capitalisation.

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares - Asset Composition Analysis

Current Asset Composition (September 2025)

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's total assets of $55.84 Million consist of 82.7% current assets and 17.3% non-current assets. Review ZJYL total liabilities to assess the company's total debt and financial obligations.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 14.0%
Accounts Receivable $6.80 Million 12.8%
Inventory $4.92 Million 9.2%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $1.10 Million 2.1%
Goodwill $0.00 0.0%

Asset Composition Trend (2018–2025)

This chart illustrates how JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See ZJYL stock price and chart for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's current assets represent 82.7% of total assets in 2025, a decrease from 83.6% in 2018.
  • Cash Position: Cash and equivalents constituted 14.0% of total assets in 2025, up from 4.6% in 2018.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 1.0% in 2018.
  • Asset Diversification: The largest asset category is accounts receivable at 12.8% of total assets.

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares Competitors by Total Assets

Key competitors of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares based on total assets are shown below.

Company Country Total Assets
Andon Health Co Ltd
SHE:002432
China CN¥29.91 Billion
Tinavi Medical Technologies Co Ltd
SHG:688277
China CN¥1.64 Billion
Mark Dynamics Indonesia Tbk PT
JK:MARK
Indonesia Rp980.33 Billion
Interojo Inc
KQ:119610
Korea ₩252.22 Billion
Daxor Corporation
NASDAQ:DXR
USA $35.90 Million
Ansell Ltd
AU:ANN
Australia AU$3.33 Billion
Nanosonics Ltd
AU:NAN
Australia AU$279.25 Million
SDI Ltd
AU:SDI
Australia AU$135.84 Million

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.95 2.11 2.47
Quick Ratio 1.64 1.82 1.57
Cash Ratio 0.00 0.00 0.00
Working Capital $21.63 Million $23.04 Million $11.55 Million

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares - Advanced Valuation Insights

This section examines the relationship between JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 4.91
Latest Market Cap to Assets Ratio 2.73
Asset Growth Rate (YoY) 16.5%
Total Assets $53.37 Million
Market Capitalization $145.85 Million USD

Valuation Analysis

Premium Asset Valuation: The market values JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's assets at a significant premium (2.73x), suggesting investors see substantial growth potential or unique competitive advantages.

Rapid Asset Growth: JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's assets grew by 16.5% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (2018–2025)

The table below shows the annual total assets of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares from 2018 to 2025.

Year Total Assets Change
2025-09-30 $53.37 Million +16.52%
2024-09-30 $45.80 Million +39.20%
2023-09-30 $32.90 Million +57.14%
2022-09-30 $20.94 Million -4.39%
2021-09-30 $21.90 Million +5.22%
2020-09-30 $20.82 Million +2.23%
2019-09-30 $20.36 Million +9.01%
2018-09-30 $18.68 Million --

About JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares

NASDAQ:ZJYL USA Medical Instruments & Supplies
Market Cap
$145.85 Million
Market Cap Rank
#17856 Global
#4206 in USA
Share Price
$1.98
Change (1 day)
+0.51%
52-Week Range
$0.12 - $3.49
All Time High
$13.81
About

Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids for people with disabilities, the elderly, and people recovering from injury. The company offers wheelchairs and wheelchair components, such as wheels and brakes; oxygen concentrators, bath aids, and rehabilitative devices, as well as infrastructures for shared wheelchairs … Read more